CN112971703A - Dynamic myopia prevention and control system and method for children and teenagers - Google Patents
Dynamic myopia prevention and control system and method for children and teenagers Download PDFInfo
- Publication number
- CN112971703A CN112971703A CN202110252883.5A CN202110252883A CN112971703A CN 112971703 A CN112971703 A CN 112971703A CN 202110252883 A CN202110252883 A CN 202110252883A CN 112971703 A CN112971703 A CN 112971703A
- Authority
- CN
- China
- Prior art keywords
- children
- module
- subassembly
- myopia
- teenagers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001491 myopia Diseases 0.000 title claims abstract description 82
- 230000004379 myopia Effects 0.000 title claims abstract description 76
- 230000002265 prevention Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 19
- 210000001508 eye Anatomy 0.000 claims abstract description 58
- 230000004438 eyesight Effects 0.000 claims abstract description 45
- 230000004410 intraocular pressure Effects 0.000 claims abstract description 30
- 230000036541 health Effects 0.000 claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 17
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 230000004382 visual function Effects 0.000 claims abstract description 12
- 238000011835 investigation Methods 0.000 claims abstract description 4
- 238000012216 screening Methods 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 12
- 210000002159 anterior chamber Anatomy 0.000 claims description 11
- 235000016709 nutrition Nutrition 0.000 claims description 11
- 210000003128 head Anatomy 0.000 claims description 8
- 230000035764 nutrition Effects 0.000 claims description 8
- 238000002645 vision therapy Methods 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 2
- 230000007246 mechanism Effects 0.000 abstract description 14
- 230000000007 visual effect Effects 0.000 abstract description 7
- 238000012544 monitoring process Methods 0.000 description 24
- 230000006399 behavior Effects 0.000 description 15
- 238000011161 development Methods 0.000 description 12
- 230000018109 developmental process Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000004308 accommodation Effects 0.000 description 9
- 210000004087 cornea Anatomy 0.000 description 9
- 238000012549 training Methods 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 229960005069 calcium Drugs 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 235000001465 calcium Nutrition 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 210000001525 retina Anatomy 0.000 description 7
- 230000003712 anti-aging effect Effects 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 239000003889 eye drop Substances 0.000 description 6
- 229940012356 eye drops Drugs 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000001502 supplementing effect Effects 0.000 description 6
- 210000003786 sclera Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 206010001497 Agitation Diseases 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 208000003464 asthenopia Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000002889 sympathetic effect Effects 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 229940069978 calcium supplement Drugs 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 210000003560 epithelium corneal Anatomy 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 235000012680 lutein Nutrition 0.000 description 3
- 239000001656 lutein Substances 0.000 description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 3
- 229960005375 lutein Drugs 0.000 description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 3
- 230000004423 myopia development Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000006550 Mydriasis Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 210000003403 autonomic nervous system Anatomy 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007321 biological mechanism Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000004397 blinking Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000003161 choroid Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000004373 eye development Effects 0.000 description 2
- 239000003885 eye ointment Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 210000004175 meibomian gland Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000036544 posture Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 241000206607 Porphyra umbilicalis Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000121219 Tricholoma Species 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002350 accommodative effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960002028 atropine sulfate Drugs 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229940041131 calcium lactate gluconate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 description 1
- 229960001160 latanoprost Drugs 0.000 description 1
- 235000014659 low sodium diet Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- MKTRXTLKNXLULX-UHFFFAOYSA-P pentacalcium;dioxido(oxo)silane;hydron;tetrahydrate Chemical compound [H+].[H+].O.O.O.O.[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O MKTRXTLKNXLULX-UHFFFAOYSA-P 0.000 description 1
- 230000005043 peripheral vision Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 208000007645 potassium deficiency Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004515 progressive myopia Effects 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 230000001179 pupillary effect Effects 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/16—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring intraocular pressure, e.g. tonometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/103—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining refraction, e.g. refractometers, skiascopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/107—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining the shape or measuring the curvature of the cornea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/117—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/117—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes
- A61B3/1173—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes for examining the eye lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H5/00—Exercisers for the eyes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
- G06V40/10—Human or animal bodies, e.g. vehicle occupants or pedestrians; Body parts, e.g. hands
- G06V40/16—Human faces, e.g. facial parts, sketches or expressions
- G06V40/172—Classification, e.g. identification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/02—Head
- A61H2205/022—Face
- A61H2205/024—Eyes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Multimedia (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Human Computer Interaction (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Rehabilitation Tools (AREA)
Abstract
The invention discloses a dynamic myopia prevention and control system and method for children and teenagers, which can monitor vision, diopter and intraocular pressure by stages by adopting the dynamic myopia prevention and control system, make corresponding behavior guidance and solution by taking eye health files of the children and the teenagers as the origin, add myopia prevention and control measures to cover 6 aspects, wherein the eye health files of the children and the teenagers comprise lens wearing history, past history, family history and other health related conditions, visual quality investigation questionnaire, vision, computer optometry, corneal curvature, comprehensive optometry, leading eyes, interpupillary distance, intraocular pressure, visual function examination and safe medication schemes, the myopia prevention and control system comprises the myopia prevention and control measures to cover 6 aspects, culture of eye consciousness, knowledge and method for myopia prevention and control and mechanisms contained in the myopia prevention and control system by taking the eye health files of the children and the teenagers as the origin, the child eyesight health management system can be used for systematically managing the eyesight health of the child, so that the aim of helping the child to control the eyesight gliding is fulfilled.
Description
Technical Field
The invention belongs to the field of myopia prevention and control systems, and particularly relates to a dynamic myopia prevention and control system and method for children and teenagers.
Background
In recent years, the myopia problem of children and teenagers is increasingly serious and the trend of low age is obvious. According to the latest data statistics, the Chinese myopia number reaches 4.5 hundred million, the myopia rate of pupils is 45.7%, the myopia rate of junior and middle school students is 74.4%, the myopia rate of high school students is 75%, the myopia rate of college students is 83.8%, and the myopia rate of 24 provinces in China exceeds 50%. More and more young parents worry about that the next generation of the parents can not get rid of the trouble of myopia like the parents, the demands of the parents are transited from 'how much glasses are matched for children' to 'how to prevent the myopia of the children', and a better eyesight health solution is hoped to be obtained. Therefore, myopia prevention and control has become a social need.
Myopia formation is a result in the eyeball development process, under the action of various comprehensive factors, the early expression of myopia formation is complex, an operable myopia early warning prediction method is not available, early discovery of myopia cannot be realized, and therefore the myopia control and treatment effect is very low.
Disclosure of Invention
The invention aims to provide a dynamic myopia prevention and control system and method for children and teenagers, which solve the problems in the prior art.
The invention is realized by the following technical scheme: a dynamic myopia prevention and control system and method for children and teenagers can monitor vision, diopter and intraocular pressure in a grading mode, corresponding behavior guidance and solution are made according to detection results of each stage, myopia prevention and control measures are added by taking eye health files of the children and the teenagers as an original point, the 6 aspects are covered, the eye health files of the children and the teenagers comprise lens wearing history, past history, family history and other health related conditions, a vision quality investigation questionnaire, vision, computer optometry, corneal curvature, comprehensive optometry, leading eyes, pupil distance, intraocular pressure, visual function inspection, eye health conditions, eye axis, corneal thickness, anterior chamber depth, height and weight, and the myopia prevention and control measures cover myopia early warning prediction, a vision reconstruction scheme, a vision training scheme, a behavior guidance scheme, a nutrition support scheme and a safe medication scheme.
Teenagers' health record, including network module, touch screen module, collection module, screening module, storage module and power module, the network module with touch screen module electric connection, the touch screen module with collection module electric connection, the collection module with screening module electric connection, the screening module with storage module electric connection, the touch screen module is including registering the unit and logging in the unit, the collection module includes manual collection subassembly, automatic collection subassembly and information retrieval subassembly, the screening module includes detection components and contrast subassembly, the storage module includes data receiving component, storage components, data output subassembly and backup assembly.
Preferably, the power supply module is electrically connected to the network module, the touch screen module, the acquisition module, the screening module and the storage module respectively.
Preferably, the network module includes a wired channel and a signal channel, the wired channel is electrically connected to the signal channel, the wired channel is mainly used for accessing a network cable, and the signal channel is mainly used for receiving and transmitting wireless signals.
Preferably, the registration unit with login unit electric connection, the registration unit includes manual entry subassembly and image acquisition subassembly, manual entry subassembly with image acquisition subassembly electric connection, the manual entry subassembly is mainly to fill in children's basic information, whether near-sighted etc. like name, age, parent's name, parents, image acquisition mainly is used for gathering children's head portrait, the login unit includes image identification subassembly and account login subassembly, the image identification subassembly with account login subassembly electric connection, the image identification subassembly is used for discerning children's head portrait.
Preferably, the manual collection assembly and the automatic collection assembly are respectively electrically connected with the information calling assembly, and the manual collection assembly mainly controls the automatic collection assembly to move through a manual control button.
Preferably, the automatic acquisition assembly comprises a camera assembly and an eye plugging assembly, and the camera assembly is electrically connected with the eye plugging assembly.
Preferably, the detection component and the comparison component are electrically connected, the detection component comprises a left eye measurement component and a right eye measurement component, and the left eye measurement component and the right eye measurement component are electrically connected.
Preferably, the data receiving component is electrically connected to the storage component and the backup component, respectively, and the storage component and the backup component are electrically connected to the data output component, respectively.
Preferably, the storage component and the backup component are respectively provided with at least two hard disks, and the storage space of each hard disk is 1T.
Preferably, the myopia early warning prediction is used for predicting the eye development speed, preventing myopia, relieving accommodation myopia and finding recessive myopia; controlling the development of myopia; preventing and early treating complications, and preventing myopia blindness.
Preferably, the visual reconstruction protocol comprises frame glasses and contact lenses.
Preferably, the vision training scheme includes ensemble training, accommodation training, eye movement training, and the like.
Preferably, the behavior guidance program mainly refers to living behaviors, and comprises a natural full spectrum concept, an anti-aging concept, attention to increase scleral collagen hardness, decrease scleral tension, increase sympathetic excitability, restore natural biological clock rhythm, attention to macular function protection, ultraviolet radiation prevention and the like.
Preferably, the nutritional support regimen includes improving microcirculation, increasing collagen stiffness, protecting macular function, supplementing trace elements, and the like.
Preferably, the safe medication scheme belongs to medical source intervention, and comprises 8 aspects:
1. relieving asthenopia, changing regulation stimulation amount and reducing regulation response lag;
2. reducing intra-ocular expansion pressure;
3. inhibition of scleral dissolution remodeling;
4. balancing autonomic nervous system, improving sympathetic nerve excitability, recovering day and night biological clock, and supplementing neurotransmitter;
5. improving microcirculation;
6. anti-aging, neural support;
RGP/OK medications: comprises the steps of tear film protection, corneal epithelium repair, antiallergic, anti-infection, meibomian gland function recovery and conjunctival sac cleaning;
8. chinese medicine.
The mechanism contained in the myopia prevention and control system comprises: (ii) biomechanical mechanism
1. Lowest intraocular pressure at head upright position → three one-writing postures
2. Squinting, blinking and intraocular pressure → timely foot correction
3. Integration and accommodation ratio and intraocular pressure → adjustment ratio
4. Growth of ocular axis development and intraocular pressure → control of intraocular pressure
5. Regulation of traction choroid → deficiency of accommodation → increase of accommodation
(II) biological geometric optical mechanism
1. Hyperopic defocus → focus of macula, eliminating hyperopic defocus
2. Refractive components matched → occult, developmental and decompensated myopia.
(III) Bio-optical mechanism
Photon mechanics → illumination time and cold light source → hot light source application
(IV) biological mechanisms
1. Rapid jump and increase of puberty
2. Biological degenerative aging mechanism → imbalance of development of refractive component
(V) biochemical mechanisms
1. Immature scleral fibers
2. Thinner balloon wall → lower body temperature or local temperature
3. Temperature pressure effect of collagen
4. Anatomical morphology basis → brain intelligence development → anti-aging
5. Basis of physiological function → intervention in visual development
The dynamic detection parameters of the invention are as follows:
primary monitoring
Monitoring the object: vision is 0.8-1.0, and the diopter value of the spherical lens is-0.50D to-0.75D
Monitoring items: vision, diopter, and intraocular pressure were monitored 1 time per half month.
Every 3 months, on the basis of monitoring vision, diopter and intraocular pressure, the eye axis, corneal curvature, anterior chamber depth, vitreous thickness, visual function examination, height and weight are monitored.
Two-stage monitoring
Monitoring the object: vision is 0.8-1.0, and the diopter value of the spherical lens is 0 to-0.25D
Monitoring items: vision, diopter, intraocular pressure were monitored 1 time per month.
Every 3 months, on the basis of monitoring vision, diopter and intraocular pressure, the eye axis, corneal curvature, anterior chamber depth, vitreous thickness, visual function examination, height and weight are monitored.
Three-level monitoring
Monitoring the object: sphere diopter value is positive
Monitoring items: every 3 months, 1 time, vision, diopter, intraocular pressure, eye axis, corneal curvature, anterior chamber depth, vitreous thickness, visual function test, height, weight were monitored.
Monitoring results and corresponding scheme
Firstly, the vision is reduced to 0.6, the myopia value after mydriasis is over-0.75D, the vision is corrected by 0.8 or more, and a vision reconstruction scheme is started.
And secondly, the eye axis grows to be more than 0.02mm every 3 months, the visual function examination is abnormal, and a visual training scheme, a behavior guidance scheme, a nutrition support scheme and a safe medication scheme are started.
Thirdly, enabling the intraocular pressure value to be 20-21 mmHg, and starting a behavior guidance scheme and a safe medication scheme.
And fourthly, starting a behavior guidance scheme and a nutrition support scheme at the stage of fast growth of height and weight.
Compared with the prior art, the invention has the beneficial effects that: the myopia prevention and control system for the teenagers comprises myopia prevention and control measures covering 6 aspects, and the training of the eye-loving consciousness by taking the eye health file of the teenagers as the origin, the knowledge and the method of the myopia prevention and control, and the mechanism contained in the myopia prevention and control system are used for systematically managing the eyesight health of the children, so that the aim of helping the children to control the eyesight to slide down is fulfilled.
Detailed Description
The present invention will be described in further detail in order to make the objects, technical solutions and advantages of the present invention more apparent. It is to be understood that the described embodiments are merely exemplary of the invention, and not restrictive of the full scope of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A dynamic myopia prevention and control system and method for children and teenagers can monitor vision, diopter and intraocular pressure in a grading mode, corresponding behavior guidance and solution are made according to detection results, and through taking a health file of the eyes of the children and the teenagers as an original point, 6 aspects are covered by adding myopia prevention and control measures, wherein the health file of the eyes of the children and the teenagers comprises a lens wearing history, a past history, a family history and other health related conditions, a vision quality investigation questionnaire, vision, computer optometry, corneal curvature, comprehensive optometry, leading eyes, pupillary distance, intraocular pressure, visual function examination, eye health conditions, an axis of the eye, corneal thickness, anterior chamber depth, height and weight, and the myopia prevention and control measures cover myopia early warning prediction, a vision reconstruction scheme, a vision training scheme, a behavior guidance scheme, a nutrition support scheme and a safe medication scheme.
Teenagers' health record, including network module, touch screen module, collection module, screening module, storage module and power module, the network module with touch screen module electric connection, the touch screen module with collection module electric connection, the collection module with screening module electric connection, the screening module with storage module electric connection, the touch screen module is including registering the unit and logging in the unit, the collection module includes manual collection subassembly, automatic collection subassembly and information retrieval subassembly, the screening module includes detection components and contrast subassembly, the storage module includes data receiving component, storage components, data output subassembly and backup assembly.
Preferably, the power supply module is electrically connected to the network module, the touch screen module, the acquisition module, the screening module and the storage module respectively.
Preferably, the network module includes a wired channel and a signal channel, the wired channel is electrically connected to the signal channel, the wired channel is mainly used for accessing a network cable, and the signal channel is mainly used for receiving and transmitting wireless signals.
Preferably, the registration unit with login unit electric connection, the registration unit includes manual entry subassembly and image acquisition subassembly, manual entry subassembly with image acquisition subassembly electric connection, the manual entry subassembly is mainly to fill in children's basic information, whether near-sighted etc. like name, age, parent's name, parents, image acquisition mainly is used for gathering children's head portrait, the login unit includes image identification subassembly and account login subassembly, the image identification subassembly with account login subassembly electric connection, the image identification subassembly is used for discerning children's head portrait.
Preferably, the manual collection assembly and the automatic collection assembly are respectively electrically connected with the information calling assembly, and the manual collection assembly mainly controls the automatic collection assembly to move through a manual control button.
The automatic acquisition assembly comprises a camera assembly and a hole plugging assembly, and the camera assembly is electrically connected with the hole plugging assembly.
The detection assembly with contrast subassembly electric connection, the detection assembly includes left eye measuring component and right eye measuring component, left eye measuring component and right eye measuring component electric connection.
The data receiving assembly is electrically connected with the storage assembly and the backup assembly respectively, and the storage assembly and the backup assembly are electrically connected with the data output assembly respectively.
The storage assembly and the backup assembly are respectively provided with at least two hard disks, and the storage space of each hard disk is 1T.
The myopia early warning is used for predicting the eye development speed, preventing myopia, relieving accommodation myopia and finding recessive myopia; controlling the development of myopia; preventing and early treating complications, and preventing myopia blindness.
The vision reconstruction solution includes frame glasses and contact lenses.
The vision training scheme comprises set training, adjustment training, eyeball movement training and the like.
The behavior guidance scheme mainly refers to living behaviors, and comprises a natural full spectrum concept, an anti-aging concept, attention on increasing sclera collagen hardness, reducing sclera tension, increasing sympathetic excitability, restoring natural biological clock rhythm, attention on yellow spot function protection, ultraviolet radiation prevention and the like.
Nutritional support regimens include improving microcirculation, increasing collagen stiffness, protecting macular function, supplementing trace elements, and the like.
The safe medication scheme belongs to medical source intervention and comprises 8 aspects:
1. relieving asthenopia, changing regulation stimulation amount and reducing regulation response lag;
2. reducing intra-ocular expansion pressure;
3. inhibition of scleral dissolution remodeling;
4. balancing autonomic nervous system, improving sympathetic nerve excitability, recovering day and night biological clock, and supplementing neurotransmitter;
5. improving microcirculation;
6. anti-aging, neural support;
RGP/OK medications: comprises the steps of tear film protection, corneal epithelium repair, antiallergic, anti-infection, meibomian gland function recovery and conjunctival sac cleaning;
8. chinese medicine.
The mechanism contained in the myopia prevention and control system comprises: (ii) biomechanical mechanism
1. Lowest intraocular pressure at head upright position → three one-writing postures
2. Squinting, blinking and intraocular pressure → timely foot correction
3. Integration and accommodation ratio and intraocular pressure → adjustment ratio
4. Growth of ocular axis development and intraocular pressure → control of intraocular pressure
5. Regulation of traction choroid → deficiency of accommodation → increase of accommodation
(II) biological geometric optical mechanism
1. Hyperopic defocus → focus of macula, eliminating hyperopic defocus
2. Refractive components matched → occult, developmental and decompensated myopia.
(III) Bio-optical mechanism
Photon mechanics → illumination time and cold light source → hot light source application
(IV) biological mechanisms
1. Rapid jump and increase of puberty
2. Biological degenerative aging mechanism → imbalance of development of refractive component
(V) biochemical mechanisms
1. Immature scleral fibers
2. Thinner balloon wall → lower body temperature or local temperature
3. Temperature pressure effect of collagen
4. Anatomical morphology basis → brain intelligence development → anti-aging
5. Basis of physiological function → intervention in visual development
Firstly, relieve visual fatigue
Eye drops of schungren
Secondly, reducing the expansion pressure in the eyeball
Eye drops of Meikaran, eye drops of latanoprost, acezamide tablet, and Nimu-Kesi tablet
Thirdly, strengthening the sclera
0.01 atropine sulfate eye drops
Fourthly, improving microcirculation
Gold multichip, dobesi, red sage root, compound thrombus clearing medicine
Protection of tear film and repair of corneal epithelium
Hailu eye liquid, Aili eye liquid, Beifushu eye liquid and eye ointment
Sixthly, anti-allergy
Naphthiramine eye drops and Eimetin eye drops
Seven, resisting infection
Tillituo eye liquid, clonidine eye liquid, tobermorite eye liquid, Dikeluo eye ointment
The behavior guidance scheme is as follows:
the full spectrum concept:
1. outdoor activity time of 2 hours a day, exposure to natural light
2. The closer the light source is to the lamp of sunlight (full spectrum, high brightness), the better, it is recommended to use an incandescent lamp as reading illumination, 60-40W, shining from the upper left. It is recommended that the reading environment be at best 500lux, consistent with the standards in the international lighting norms.
Firstly, improving microcirculation:
moderate physical exercise such as rope skipping, swimming, table tennis, badminton, etc.
Thirdly, maintaining normal circadian rhythm and restoring natural biological clock rhythm:
ensure sufficient sleep and avoid night light.
Fourthly, reducing the scleral tension:
1. "3 20", i.e., the 20-20-20 rule: read (write, read, use cell phone, computer, etc.) for 20 minutes every short distance, rest for 20 seconds, and look out of 20 feet (6 m).
2. "3 1" namely "a fist, one size, one inch": when reading and writing characters, the chest is a fist away from the desk; eyes are one ruler (33 cm) away from the book; the pen holding finger is one inch away from the pen point. (of which the most important is a ruler, a reading distance of 33 cm!)
And fifthly, increasing the hardness of sclera collagen:
1. the eyes are cold-applied before sleeping at night to relieve asthenopia.
2. Not choking, not eating too fine, eating more coarse food grains, vegetables and fruits and chewing more.
3. The sweet food and the carbonated beverage are not eaten.
The myopia early warning prediction is as follows: the myopia early warning prediction needs data such as the length of an eye axis, the curvature of a cornea and the depth of an anterior chamber.
Myopia number at 18 years = (normal reference value of axis of eye-axis of the age group) × 3.00+ (43-corneal horizontal diopter D) + (21-phaco diopter)
Lens diopter calculation formula:
wherein N =1336, L = ocular axis mm, K = corneal horizontal diopter D, C = anterior chamber depth mm
The vision training scheme is as follows:
the visual reconstruction scheme is as follows:
first, cornea moulding mirror
Orthokeratology lenses are one of the internationally recognized methods for effectively retarding the development of myopia at present.
The cornea shaping mirror is commonly called as 'OK mirror', is designed in inverse geometry and 'multi-arc', and flattens the central area of the cornea through physical action to temporarily reduce the myopia degree and achieve the effect of clear vision in the daytime. Meanwhile, the second arc area and the third arc area of the lens can help the lens center to be positioned, improve the far vision defocusing state of peripheral retina, effectively delay the increase speed of the axis of the eye and achieve the effect of delaying the increase speed of the myopia of teenagers.
The cornea shaping mirror is worn at night, and the bending degree of the front surface of the cornea is gradually and scientifically changed by wearing the cornea shaping mirror during sleeping at night, so that the effect of temporarily correcting myopia is achieved. When sleeping, the glasses are worn and taken off in the morning, daily activities are not affected, and the glasses can participate in a plurality of outdoor and sports activities. Meanwhile, as the child wears the glasses at home, even if the child cannot operate the glasses, parents can substitute the work at all.
The cornea shaping mirror is suitable for myopia patients of over 8 years old, with myopia degree between-0.75D to-5.00D, compliant cornea astigmatism within-1.5D, corneal curvature flatness K value between 40.00D and 46.00D, and no contact lens related contraindication.
Glasses with two frames
1. Haoya new happy learning lens
The theory of myopic defocus adopted by new Learn lenses is that the fovea of the retina develops hyperopic defocus (accommodative lag) when looking near, causing the axis of the eye to increase. Therefore, when the lens is designed, a part of light rays pass through the micro lens to generate a near-vision defocusing signal in the eye, and the increase of the axis of the eye is inhibited; another portion of the light passes through the microlens and the gap between the microlenses (normal refractive power), and a clear image signal is formed in the eye to see the object. By this unique design of the multi-point micro-lenses, it is achieved on spectacle lenses: meanwhile, the optical lens has the functions of refractive correction and myopic defocus and presents the myopic defocus theory.
2. Caisy grown happy lens
The growth happy lens applies the peripheral vision control technology and is beneficial to delaying the development speed of myopia. Myopia is the focusing of an image of a distant object in front of the retina, resulting in a blurred distant vision. Most children's myopia is due to elongation of the axis of the eye. The near vision eye corrected by the Zeiss growing music lens has the advantages that the image of the central part is projected on the retina, the image of the peripheral part is projected in front of (or above) the retina, the lengthening of the eye axis of the child is inhibited, and the development speed of the near vision is slowed down.
3. Common single-vision lens
For myopic eyes corrected with a conventional single vision lens, the central part of the image is projected on the retina, but the peripheral part is projected behind the retina.
The nutritional support program is:
anti-senility
1. Supplementing various trace elements and vitamins.
Various nutritional components have an effect on biochemical indicators associated with myopia. Can supplement comprehensive and sufficient nutrition, and promote the stability of connective tissue, especially sclera; excessive feedback due to image quality is suppressed.
2. Low salt diet and intake of sufficient amount of potassium
High salt diet can impair microcirculation and vasodilation, and potassium deficiency can cause smooth muscle weakness. Potassium-rich food: tricholoma, yellow mushroom, laver, longan, hazelnut, soybean, black bean, squid, etc.
3. Supplementation of arginine
Arginine is an essential amino acid only in the growth phase, and the lack of arginine is a cause of myopia progression in children.
Arginine-rich food: dried bean curd sticks, bean curd sheets, soybeans, shelled watermelon seeds, shelled pumpkin seeds, shelled peanuts, pork tendons, beef tendons, curry beef jerky and the like.
Secondly, increasing the hardness of the collagen and supplementing calcium.
Calcium is a mineral essential for human growth and development, and has an important role in bone formation. The calcium can be supplemented by food supplements such as milk and yogurt, and calcium-containing food. It can also be supplemented with drugs, including calcium carbonate, calcium lactate, and calcium gluconate. It should be noted that the absorption of calcium requires the assistance of vitamin D3, so that the supplement of vitamin D3 can achieve a better calcium supplement effect. After calcium supplement, the strengthening exercise is required to ensure that the calcium can be fully mobilized, so that the calcium can be supplemented to the bone. Therefore, the calcium supplement needs diet, exercise, living habits and medicines to be processed simultaneously in multiple aspects, and the effect is better.
And thirdly, the function of the yellow spots is protected, and lutein is supplemented.
Macular pigment is composed of two carotenoids, lutein and zeaxanthin (isomers of lutein), and protects eye health from two aspects: firstly, it can filter and absorb blue light with high energy; second, it is an antioxidant that scavenges free radicals and reactive oxygen-containing species generated by light.
The dynamic detection parameters of the invention are as follows:
primary monitoring
Monitoring the object: vision is 0.8-1.0, and the diopter value of the spherical lens is-0.50D to-0.75D
Monitoring items: vision, diopter, and intraocular pressure were monitored 1 time per half month.
Every 3 months, on the basis of monitoring vision, diopter and intraocular pressure, the eye axis, corneal curvature, anterior chamber depth, vitreous thickness, visual function examination, height and weight are monitored.
Two-stage monitoring
Monitoring the object: vision is 0.8-1.0, and the diopter value of the spherical lens is 0 to-0.25D
Monitoring items: vision, diopter, intraocular pressure were monitored 1 time per month.
Every 3 months, on the basis of monitoring vision, diopter and intraocular pressure, the eye axis, corneal curvature, anterior chamber depth, vitreous thickness, visual function examination, height and weight are monitored.
Three-level monitoring
Monitoring the object: sphere diopter value is positive
Monitoring items: every 3 months, 1 time, vision, diopter, intraocular pressure, eye axis, corneal curvature, anterior chamber depth, vitreous thickness, visual function test, height, weight were monitored.
Monitoring results and corresponding scheme
Firstly, the vision is reduced to 0.6, the myopia value after mydriasis is over-0.75D, the vision is corrected by 0.8 or more, and a vision reconstruction scheme is started.
And secondly, the eye axis grows to be more than 0.02mm every 3 months, the visual function examination is abnormal, and a visual training scheme, a behavior guidance scheme, a nutrition support scheme and a safe medication scheme are started.
Thirdly, enabling the intraocular pressure value to be 20-21 mmHg, and starting a behavior guidance scheme and a safe medication scheme.
And fourthly, starting a behavior guidance scheme and a nutrition support scheme at the stage of fast growth of height and weight.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (6)
1. A dynamic myopia prevention and control system and method for children and teenagers is characterized in that: the vision, diopter and intraocular pressure can be monitored in a grading mode by adopting a dynamic prevention and control system, corresponding behavior guidance and solution can be made through detection results in each stage, the children and teenagers eye health file is taken as an original point, and the method covers 6 aspects by adding myopia prevention and control measures, wherein the children and teenagers eye health file comprises a lens wearing history, a past history, a family history and other health related conditions, a vision quality investigation questionnaire, the vision, computer optometry, corneal curvature, comprehensive optometry, leading eyes, interpupillary distance, intraocular pressure, visual function examination, eye health conditions, an axis of the eye, corneal thickness, anterior chamber depth, height and weight, and the myopia prevention and control measures cover myopia early warning prediction, a vision reconstruction scheme, a vision training scheme, a behavior guidance scheme, a nutrition support scheme and a safety medication scheme.
2. The system and method of claim 1 for dynamic prevention and control of myopia in children and teenagers, wherein the system comprises: teenagers' health record, including network module, touch screen module, collection module, screening module, storage module and power module, the network module with touch screen module electric connection, the touch screen module with collection module electric connection, the collection module with screening module electric connection, the screening module with storage module electric connection, the touch screen module is including registering the unit and logging in the unit, the collection module includes manual collection subassembly, automatic collection subassembly and information retrieval subassembly, the screening module includes detection components and contrast subassembly, the storage module includes data receiving component, storage components, data output subassembly and backup assembly.
3. The system and method of claim 2 for dynamic prevention and control of myopia in children and teenagers, wherein the system comprises: the power supply module is electrically connected with the network module, the touch screen module, the acquisition module, the screening module and the storage module respectively.
4. The system and method of claim 2 for dynamic prevention and control of myopia in children and teenagers, wherein the system comprises: the network module comprises a wired channel and a signal channel, the wired channel is electrically connected with the signal channel, the wired channel is mainly used for accessing a network cable, and the signal channel mainly aims at receiving and transmitting wireless signals.
5. The system and method of claim 2 for dynamic prevention and control of myopia in children and teenagers, wherein the system comprises: the registration unit with login unit electric connection, the registration unit includes manual entry subassembly and image acquisition subassembly, manual entry subassembly with image acquisition subassembly electric connection, the manual entry subassembly is mainly to fill in children's basic information, whether near-sighted etc. like name, age, parent's name, parent, image acquisition mainly is used for gathering children's head portrait, the login unit includes image identification subassembly and account login subassembly, the image identification subassembly with account login subassembly electric connection, the image identification subassembly is used for discerning children's head portrait.
6. The system and method of claim 2 for dynamic prevention and control of myopia in children and teenagers, wherein the system comprises: the manual acquisition assembly and the automatic acquisition assembly are respectively electrically connected with the information calling assembly, and the manual acquisition assembly mainly controls the movement of the automatic acquisition assembly through a manual control button.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110252883.5A CN112971703A (en) | 2021-03-09 | 2021-03-09 | Dynamic myopia prevention and control system and method for children and teenagers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110252883.5A CN112971703A (en) | 2021-03-09 | 2021-03-09 | Dynamic myopia prevention and control system and method for children and teenagers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112971703A true CN112971703A (en) | 2021-06-18 |
Family
ID=76335916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110252883.5A Pending CN112971703A (en) | 2021-03-09 | 2021-03-09 | Dynamic myopia prevention and control system and method for children and teenagers |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112971703A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114052654A (en) * | 2021-11-15 | 2022-02-18 | 云智道智慧医疗科技(广州)有限公司 | Dynamic eye health management system |
| CN114788682A (en) * | 2022-06-27 | 2022-07-26 | 华慧健(天津)科技有限公司 | Portable intelligent eye health management system based on eye and face feature image processing |
| CN115005765A (en) * | 2022-04-22 | 2022-09-06 | 南宁博艾特医疗器械有限公司 | Quick accurate detecting system to teenager's eyesight |
-
2021
- 2021-03-09 CN CN202110252883.5A patent/CN112971703A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114052654A (en) * | 2021-11-15 | 2022-02-18 | 云智道智慧医疗科技(广州)有限公司 | Dynamic eye health management system |
| CN115005765A (en) * | 2022-04-22 | 2022-09-06 | 南宁博艾特医疗器械有限公司 | Quick accurate detecting system to teenager's eyesight |
| CN114788682A (en) * | 2022-06-27 | 2022-07-26 | 华慧健(天津)科技有限公司 | Portable intelligent eye health management system based on eye and face feature image processing |
| CN114788682B (en) * | 2022-06-27 | 2022-10-04 | 华慧健(天津)科技有限公司 | Portable intelligent eye health management system based on eye and face feature image processing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112971703A (en) | Dynamic myopia prevention and control system and method for children and teenagers | |
| Rogers | The eye: the physiology of human perception | |
| CN110068937A (en) | Ophthalmic lens with the non-coaxial area of optics for myopia control | |
| US10330939B1 (en) | Light control devices and methods for regional variation of visual information and sampling | |
| Khurana | Comprehensive ophthalmology | |
| Cassel | The eye book: a complete guide to eye disorders and health | |
| Biswas et al. | The influence of the environment and lifestyle on myopia | |
| Nikdel et al. | Assessment of the Responses of the Artificial Intelligence–based Chatbot ChatGPT-4 to Frequently Asked Questions About Amblyopia and Childhood Myopia | |
| CN103417525B (en) | Application of zinc gluconate tablets and six vitamin pills in treating ametropic eyes | |
| Silva et al. | Analysis of the disturbances caused by intraocular forced convection mechanism failure | |
| Yang et al. | Review of Risk Factors and Intervention of Myopia in Children and Adolescents | |
| Digirolamo | The Big Book of Family Eye Care: A Contemporary Reference for Vision and Eye Care | |
| Chen et al. | Influencing Factors and Prevention of Myopia in College Students | |
| Evgenievna | Belgorod State National Research University, Belgorod, Russia E-mail: 1313819@ bsu. edu. ru Scientific advisor | |
| CN216210289U (en) | Intelligent glasses of myopia prevention training usefulness | |
| Grüsser | Vision and eye movements | |
| US20230411021A1 (en) | System and method for determining an appropriate moment for modifying or changing an initial myopia control solution | |
| Michaud et al. | The Three pillars of Myopia Control in Practice | |
| CN205787422U (en) | A kind of adjustable type picture frame | |
| CN101004487A (en) | New application of eyeglasses in procedure of eyesight rehabilitation, preparation method, and method of application | |
| Fatima et al. | Correlation between Sleeping Time and Myopia Patients under Age 10-50 Years in Pakistan | |
| CN207575330U (en) | The open remote optical R/W device in the visual field | |
| Angart | Improve Your Eyesight Naturally: See Results Quickly | |
| Salmon et al. | Visual function | |
| Hirebeel | Study to Evaluate the Efficacy of Jeevanthyadi Ghrita Tarpana and Netrya Granules in Simple Myopia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210618 |